TradingHolo

The whole market. One view. Market data from our own platform. Not investment advice. Prices in listing currency with AED alongside; market cap in USD. Live = streaming now; Delayed 15 min where the exchange requires it; At close = last official close.

News Calendar Economy IPOs ETFs Account

⌂Home ◈Markets ▦Screener 📈Tools ◎Portfolio

Skip to content

DFM General5,851.39−0.27%FTSE ADX9,783.24−0.26%TASI10,123.62−0.65%QE Index8,632.66−0.01%S&P 5007,690.73+0.41%Nasdaq 10029,529.34+1.17%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100165,966.09−0.27%DFM:EMIRATESNBDAED 31.50−0.25%ADX:IHCAED 352.00−0.17%SAU:2222SAR 25.80+0.00%DSMD:QNBKQAR 15.66+2.29%NAS:NVDA$217.09+1.38%NYSE:TSM$420.22+1.84%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 299.47+0.12%Gold$4,132.28−0.21%Brent$109.32+0.09%BTC$81,449.97−0.69%ETH$2,390.76−0.69%DFM General5,851.39−0.27%FTSE ADX9,783.24−0.26%TASI10,123.62−0.65%QE Index8,632.66−0.01%S&P 5007,690.73+0.41%Nasdaq 10029,529.34+1.17%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100165,966.09−0.27%DFM:EMIRATESNBDAED 31.50−0.25%ADX:IHCAED 352.00−0.17%SAU:2222SAR 25.80+0.00%DSMD:QNBKQAR 15.66+2.29%NAS:NVDA$217.09+1.38%NYSE:TSM$420.22+1.84%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 299.47+0.12%Gold$4,132.28−0.21%Brent$109.32+0.09%BTC$81,449.97−0.69%ETH$2,390.76−0.69%

Stock markets

🇦🇪UAEDFM · ADX · DFM GeneralClosed 🇸🇦Saudi ArabiaTadawul · TASIClosed 🇶🇦QatarQSE · QE GeneralClosed 🇺🇸United StatesNasdaq · NYSE · S&P 500Closed 🇮🇳IndiaNSE · BSE · Nifty 50Closed 🇵🇰PakistanPSX · KSE-100Closed

Other assets

₿CryptoRanked by volume · 24/7 🥇Gold, FX & economyDubai gold, AED crosses, rates ◫ETFsIndex, sector and gold funds

Explore

▦Market mapEvery market as a heatmap 📅Calendar & IPOsEarnings, dividends, listings, releases ⌁Options flow · Ownership · PoliticsUS filings and tapes

⚲Stock screenerAll six markets, one row per company ★Ready-made screensStarting points with a point of view 📁My saved screensSaved rules with alerts on new matches ⇄CompareUp to five, side by side

📈ChartingDrawings, indicators, replay ▶Strategy MakerWrite a rule, test it on history ⇄CompareSide by side 🔔AlertsPrice, earnings, screens, strategies

⌕

Sign in Create account👤

Gujarat Themis Biosyn Ltd · Overview · TradingHolo

Markets › India › NSE › GUJTHEM

G

Gujarat Themis Biosyn Ltd

NSE:GUJTHEMHealthcare

₹373.40+0.91%At closeAt close · Fri 16 Oct · ≈ AED 14.42 · Market cap $507.27M

🔔 Alert▶ Test a strategy

Overview Chart Financials Valuation Forecasts Dividends News Profile

1D

+0.9%

1M

−9.6%

3M

+0.4%

6M

+22.9%

1Y

−18.5%

Why it's moving today

No company news in the last day; the move tracks its market and sector.

GUJTHEM +0.91% today

✦ This week in three lines

No written digest yet for GUJTHEM. The figures on this page are the source when one is written.

Financials

INR billions · annual5Y CAGR +12.9%

Valuation

P/E vs sector103.4× vs 27.5×

Price / Book vs sector16.8× vs 3.1×

Price / Sales vs sector29.1× vs 3.0×

Price / Free cash flow vs sector−37.8× vs 1.0×

cheap for itself (53.0×)expensive for itself (100.7×)

Forecasts

No analyst coverage for GUJTHEM yet.

Dividends

Yield0.2%

Annual payout₹0.6700

Payout ratio15.6%

Next ex-date—

Years of growth2

Latest news

All GUJTHEM news →

BUCyril Amarchand Mangaldas acted as counsel to EAAA India Alternatives Limited and Avendus Finance Private Limited in connection with a secured financing of INR 585 crores raised by Gujarat Th

Businessworld · 11 d ago

MOGujarat Themis completes Rs 1,220-crore funding for Japan acquisition

moneycontrol · 32 d ago

CNGujarat Themis Biosyn approves plan to raise up to ₹585 crore through NCDs

cnbctv · 39 d ago

Key facts

At close · Fri 16 Oct

Market cap (USD)$507.27M

P/E103.4×

Dividend yield0.2%

52-week range₹225.05 – ₹479.00

Avg volume (20d)307,185

Shares outstanding130,152,000

Beta0.34

Next earnings—

Radar Score

54

Value13

Quality90

Momentum45

Income68

Peer percentile within India Healthcare0–100 · null when more than one input is missing

About

Gujarat Themis Biosyn Limited functions as a pharmaceutical company, specializing in the production of various drugs. Its key pharmaceutical offerings include Rifamycin and Lovastatin. The company was incorporated on December 11, 1981, and maintains its headquarters in Mumbai, India.

SectorHealthcare

IndustryNormal

ExchangeNSE

Peers

SUNSE:SUNPHARMASun Pharmaceuticals Industries Ltd · 🇮🇳 NSE

36.8×−0.29%

DINSE:DIVISLABDivi's Laboratories Ltd · 🇮🇳 NSE

93.5×+1.27%

TONSE:TORNTPHARMTorrent Pharmaceuticals Ltd · 🇮🇳 NSE

81.0×−0.55%

APNSE:APOLLOHOSPApollo Hospitals Enterprise Ltd · 🇮🇳 NSE

58.8×+0.01%